數位轉型 (DX) 使用案例的分類法(2020年):生命科學
IDC's Worldwide Digital Transformation Use Case Taxonomy, 2020: Life Sciences
|出版日期||內容資訊||英文 22 Pages
|數位轉型 (DX) 使用案例的分類法(2020年):生命科學 IDC's Worldwide Digital Transformation Use Case Taxonomy, 2020: Life Sciences|
|出版日期: 2020年07月17日||內容資訊: 英文 22 Pages|
This IDC study discusses how digital transformation accurately characterizes the life science industry's ongoing efforts to transform itself as it seeks to find new paths to innovation, optimize operational efficiency and effectiveness, and regain long-term sustainability. As in other industries, the digital transformation journey begins with a common definition of the mission, strategic priorities, and programs so that individual projects or use cases can better align with a life science company's overall goals and objectives."Digital transformation in the life sciences is more important than ever, with advances in technology beginning to streamline the more effective use of data, information, and knowledge across the life science enterprise. Where value can be demonstrated, digital transformation initiatives are creating new paths to progress, accelerating time to market and improving patient connectivity and satisfaction," says Alan S. Louie, research director and head, Life Science Practice, IDC Health Insights."Digital transformation in the life science industry is moving forward rapidly. 3rd Platform technologies such as cloud, mobile, big data and analytics, and social data are already woven into the life sciences commercial arena. Emerging technologies like AI and RPA are accelerating productivity for commercial teams by maximizing message impact and relevance while reducing duplicate or confusing interactions with HCPs. In life science supply chains, IoT networks and platforms are enabling tracking and monitoring of sensitive and rare biologic drugs, allowing rapid deployment to patients in critical need around the globe. From the manufacturing floor to doctors' offices, digital technology is improving quality, efficiency, and patient experience," says Michael Townsend, research director, Commercial Life Sciences, IDC Health Insights.